Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Astra acquiring Fisons R&D programs in non-respiratory areas for $321 mil.

Executive Summary

ASTRA ACQUIRING FISONS R&D PROGRAMS IN NON-RESPIRATORY AREAS for [pound]202 mil. ($321.2 mil.), the companies announced March 17. The agreement in principle calls for Astra AB to acquire Fisons' U.K. research facilities in Loughborough and its R&D operations from Rochester, N.Y. Astra is not acquiring any U.S. facilities from Fisons. Astra will add approximately 900 Fisons research employees from the two sites; 200 will remain with Fisons.

Latest Headlines
See All
UsernamePublicRestriction

Register

PS025903

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel